Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.
Most participants first33,758 with no events in either group come last121 to 140 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| E-MOTIVE Intervention vs Usual Care: Number of Women With Laparotomy With Compression Sutures Postpartum Until Discharge From the Health Facility | 1 of 49,101 1 of 50,558 | 0.0 points -0.0 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women With Hysterectomy Postpartum Until Discharge From the Health Facility | 11 of 49,101 6 of 50,558 | 0.0 points -0.0 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women With Laparotomy Postpartum Until Discharge From the Health Facility | 13 of 49,101 9 of 50,558 | 0.0 points -0.0 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: The Primary Outcome is a Composite of the Following Three Clinical Outcomes: 1) Severe PPH Defined as Blood Loss ≥1000 ml or; 2) Postpartum Laparotomy for Bleeding or; 3) Postpartum Maternal Death From Bleeding. Please See Below for Further Details. | 794 of 49,101 2,139 of 50,558 | -2.6 points -2.8 to -2.4 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women Admitted to Intensive Care Unit (ICU) Until Discharge From the Health Facility | 7 of 49,101 32 of 50,558 | -0.0 points -0.1 to -0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Number of Women With Hysterectomy for Bleeding Postpartum Until Discharge From the Health Facility | 9 of 49,101 6 of 50,558 | 0.0 points -0.0 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: deaths from any cause | 17 of 49,101 28 of 50,558 | -0.0 points -0.0 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: Postpartum Laparotomy for Bleeding Until Discharge From the Health Facility | 12 of 49,101 7 of 50,558 | 0.0 points -0.0 to 0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| E-MOTIVE Intervention vs Usual Care: serious adverse events | 7 of 49,101 32 of 50,558 | -0.0 points -0.1 to -0.0 | 99,659 | NCT04341662 A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth |
| PRIM-ER vs Control: deaths from any cause | 13,910 of 48,464 14,179 of 50,458 | 0.6 points 0.0 to 1.2 | 98,922 | NCT03424109 Primary Palliative Care for Emergency Medicine (PRIM-ER) |
| Point of Care vs Direct Patient Engagement: Rates of Testing | 757 of 51,693 717 of 43,930 | -0.2 points -0.3 to -0.0 | 95,623 | NCT04746794 Early Detection of GEnetic Risk (EDGE) |
| Point of Care vs Direct Patient Engagement: Rates of Screening | 9,892 of 51,693 3,813 of 43,930 | 10.5 points 10.0 to 10.9 | 95,623 | NCT04746794 Early Detection of GEnetic Risk (EDGE) |
| Intervention Arm Stage 1 vs Intervention Arm Stage II: deaths from any cause | 1,217 of 79,818 18 of 5,447 | 1.2 points 1.0 to 1.3 | 85,265 | NCT01864603 Sustainable East Africa Research in Community Health |
| 13vPnC vs Placebo: Number of Participants With First Episode of Nonbacteremic/Noninvasive (NB/NI) Vaccine-type Community-acquired Pneumonia (VT-CAP) | 33 of 42,240 60 of 42,256 | -0.1 points -0.1 to -0.0 | 84,496 | NCT00744263 Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults |
| 13vPnC vs Placebo: Number of Participants With First Episodes of Vaccine-type Invasive Pneumococcal Disease (VT-IPD) Cases | 7 of 42,240 28 of 42,256 | -0.0 points -0.1 to -0.0 | 84,496 | NCT00744263 Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults |
| 13vPnC vs Placebo: Number of Participants With First Episode of Confirmed Vaccine-type Community-acquired Pneumonia (VT-CAP) | 49 of 42,240 90 of 42,256 | -0.1 points -0.2 to -0.0 | 84,496 | NCT00744263 Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults |
| PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of IPD at 5-7 Years of Follow-up | 32 of 31,770 54 of 48,523 | -0.0 points -0.1 to 0.0 | 80,293 | NCT05794191 A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV |
| Intervention vs Control: serious adverse events | 1 of 52,526 0 of 27,513 | 0.0 points -0.0 to 0.0 | 80,039 | NCT06057727 Behavioral Economics to Improve Flu Vaccination Using EHR Nudges |
| PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of PP at 5-7 Years of Follow-up | 49 of 31,660 69 of 48,369 | 0.0 points -0.0 to 0.1 | 80,029 | NCT05794191 A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV |
| Anesthesia Control Tower Monitoring vs Standard of Care Arm: deaths from any cause | 866 of 39,810 899 of 39,750 | -0.1 points -0.3 to 0.1 | 79,560 | NCT03923699 Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety |
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=7
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT04341662-91b919c1",
"title": "E-MOTIVE Intervention vs Usual Care: Number of Women With Laparotomy With Compression Sutures Postpartum Until Discharge From the Health Facility",
"summary": "1 of 49101 against 1 of 50558; risk difference 0.0 points, 95% interval -0.0 to 0.0; NCT04341662, A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth",
"record": "/library/comparisons/NCT04341662-91b919c1",
"nct_id": "NCT04341662",
"kind": "outcome",
"participants": 99659,
"risk_difference": {
"value": 5.869205678759168e-7,
"lower": -0.00009318518695442179,
"upper": 0.0000969706999198734
},
"group_1": "1 of 49,101",
"group_2": "1 of 50,558",
"difference": "0.0 points",
"interval": "-0.0 to 0.0",
"trial_title": "A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth"
},
{
"id": "NCT04341662-96369f81",
"title": "E-MOTIVE Intervention vs Usual Care: Number of Women With Hysterectomy Postpartum Until Discharge From the Health Facility",
"summary": "11 of 49101 against 6 of 50558; risk difference 0.0 points, 95% interval -0.0 to 0.0; NCT04341662, A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth",
"record": "/library/comparisons/NCT04341662-96369f81",
"nct_id": "NCT04341662",
"kind": "outcome",
"participants": 99659,
"risk_difference": {
"value": 0.00010535244334778625,
"lower": -0.00006626934917397676,
"upper": 0.0002937776938744959
},
"group_1": "11 of 49,101",
"group_2": "6 of 50,558",
"difference": "0.0 points",
"interval": "-0.0 to 0.0",
"trial_title": "A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "None stated"
}
],
"next": "/api/comparisons/v1?page=8",
"request_id": "FF0-uiJum3dmlJod"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant